Alivus Life Sciences Ltd.

Pursuant to regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, Alivus Life Sciences has informed that it enclosed the Press Release on the Unaudited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2024.

The above information is a part of company’s filings submitted to BSE.